3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
12
Glioblastoma
12
Carcinoma, Non-Small-Cell Lung
12
Prostatic Neoplasms
11
Oropharyngeal Neoplasms
10
Breast Neoplasms
10
Glioma
8
Urinary Bladder Neoplasms
7
Squamous Cell Carcinoma of Head and Neck
6
Esophageal Neoplasms
6
Sarcoma
5
Neoplasm Metastasis
5
Mouth Neoplasms
5
Carcinoma
5
Burkitt Lymphoma
5
Astrocytoma
5
Uterine Cervical Neoplasms
4
Rhabdomyosarcoma
4
Pancreatic Neoplasms
4
Liposarcoma
4
Laryngeal Neoplasms
4
Histiocytoma, Malignant Fibrous
4
Gliosarcoma
4
Carcinoma, Hepatocellular
4
Brain Neoplasms
4
Adenocarcinoma of Lung
4
Adenocarcinoma Of Esophagus
4
Triple Negative Breast Neoplasms
3
Stomach Neoplasms
3
Sarcoma, Synovial
3
Interventions
X-Rays
7
Phantoms, Imaging
7
Magnetic Resonance Spectroscopy
7
Specimen Handling
6
Nuclear Medicine Department, Hospital
5
Biopsy
4
tazemetostat
3
Cyclophosphamide
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
palbociclib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
Vincristine
2
Topotecan
2
Nivolumab
2
Methotrexate
2
LY3023414
2
Etoposide
2
Cisplatin
2
Carboplatin
2
talazoparib
1
selinexor
1
pembrolizumab
1
olaparib
1
irinotecan sucrosofate
1
fludarabine phosphate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Rhabdoid Tumor
×
Radiation
×
90 days
×
Clear all
No trials found.